Unichem receives US FDA nod for prostate drug alfuzosin
Alfuzosin hydrochloride extended release tablet, a generic version of Concordia Pharmaceuticals' Uroxatral tablet, is used in treating prostatic hyperplasia
Alfuzosin hydrochloride extended release tablet, a generic version of Concordia Pharmaceuticals’ Uroxatral tablet, is used in treating prostatic hyperplasia.
The product will be commercialised from Unichem's Goa plant, while the active pharmaceutical ingredients (API) for the product would also be made in-house at Pithampur plant.